蕭 志豪

Medicine & Life Sciences

1. Urinary Bladder Neoplasms 100%
2. Cytokine-Induced Killer Cells 95%
3. Carboplatin 93%
4. Urinary Bladder 90%
5. Spermatic Cord Torsion 79%
6. Mefloquine 78%
7. Prostatic Neoplasms 66%
8. T-Lymphocytes 63%
9. Chemoradiotherapy 59%
10. Neoplasms 52%
11. Mesenchymal Stem Cells 49%
12. Urachal cancer 48%
13. Xanthogranulomatous Pyelonephritis 44%
14. Malacoplakia 44%
15. Agammaglobulinaemia Tyrosine Kinase 40%
16. Angiofibroma 39%
17. Urinary Catheterization 39%
18. Intraepithelial Lymphocytes 35%
19. Recurrence 35%
20. Scrotum 34%
21. Sperm Motility 33%
22. Urinary Retention 33%
23. Germ Cells 33%
24. Testis 32%
25. Type 2 Diabetes Mellitus 31%
26. Adenosine Monophosphate 30%
27. Urinary Incontinence 30%
28. Extracellular Signal-Regulated MAP Kinases 30%
29. Hemangioma 30%
30. Adenocarcinoma of Lung 29%
31. Wounds and Injuries 29%
32. Ureter 29%
33. Cohort Studies 28%
34. Infertility 28%
35. Nephrectomy 27%
36. Carcinoma 27%
37. Reactive Oxygen Species 27%
38. ErbB Receptors 26%
39. Pathology 26%
40. Vitamin D 25%
41. Spermatozoa 25%
42. Protein Kinases 25%
43. Drug Resistance 25%
44. Oxidoreductases 25%
45. Ovarian Neoplasms 25%
46. Conservative Treatment 24%
47. Hyperplasia 24%
48. Renal Insufficiency 24%
49. Rupture 23%
50. Docetaxel 23%